NIAID scientists report single dose elicited long-term protection
Two genetically modified broadly neutralizing antibodies protected rhesus macaques from an HIV-like virus, report scientists at the NIAID. After introducing genetic mutations into two potent HIV bNAbs, researchers prepared intravenous infusions of two bNAbs known as 3BNC117-LS and 10-1074-LS. April 16, 2018